Latest News about SAGE
Recent news which mentions SAGE
Why Shares of Sage Therapeutics Climbed 15.6% This Week
June 03, 2022
From Motley Fool
1 Reason to Buy Biogen Now, and 1 Reason to Wait
May 05, 2022
From Motley Fool
From MarketWatch
From Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
From Benzinga
Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder
May 02, 2022
From Benzinga
From Benzinga
Is This Biotech Stock Worth the Trouble?
April 23, 2022
From Motley Fool
Sage Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 21, 2022
Tickers
SAGE
From Benzinga
From Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
From Benzinga
From InvestorPlace
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
From Benzinga
56 Biggest Movers From Yesterday
February 17, 2022
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
From Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.